Who will have access to the samples, and for what purpose(s)?
• Inform subjects if other investigators will be given access to samples (e.g., via a Tissue Bank arrangement). Explain how the patient’s identity will be kept confidential, specifying if tissue and/or MR data released to other investigators will be linked with personal information (e.g., the patient’s name or other personal identifiers) if the tissue/data are released to investigators using the Tissue Bank. Note that if personal identifiers will be attached to these tissue/data samples, specific consent from the subject will need to be obtained. • If a new study proposes secondary use of biological specimens, i.e., use of samples collected for a previously conducted study, an assessment will be made by the IRB regarding whether or not the consent that was obtained for the first study is applicable to the second. If the purpose of the new study differs significantly from the purposes stated in the original study, and the specimens are identifiable, obtaining new consent will be require
